Mitsui & Co., Ltd.
MITSFOTCIndustrials● Active
$32.57
+$1.57(+5.06%)
Market Cap$92.3B
P/E Ratio—
52W High$42.2
52W Low$19.5
Mitsui & Co., Ltd.（MITSF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MITSF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.839T | $0.922T | $1.064T | $1.131T | $0.915T |
| Depreciation & Amort. | $0.335T | $0.314T | $0.294T | $0.277T | $0.301T |
| Stock-Based Comp. | $0.000T | $0.000T | $0.000T | $0.000T | $0.000T |
| Change in Working Capital | ($0.136T) | ($0.051T) | ($0.236T) | ($0.235T) | ($0.401T) |
| Net Cash from Operations | $0.959T | $1.018T | $0.864T | $1.048T | $0.807T |
| Investing Activities | |||||
| Capital Expenditure | ($1.115T) | ($0.346T) | ($0.295T) | ($0.228T) | ($0.186T) |
| Purchases of Investments | ($0.210T) | ($0.057T) | $0.000T | ($0.351T) | ($0.225T) |
| Sales of Investments | $0.239T | $0.164T | $0.106T | $0.367T | $0.150T |
| Net Cash from Investing | ($1.063T) | ($0.162T) | ($0.428T) | ($0.178T) | ($0.279T) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.201T) | ($0.400T) | ($0.139T) | ($0.270T) | ($0.175T) |
| Dividends Paid | ($0.304T) | ($0.274T) | ($0.242T) | ($0.198T) | ($0.148T) |
| Debt Issued / Repaid | $0.664T | $0.044T | ($0.547T) | ($0.049T) | ($0.137T) |
| Net Cash from Financing | $0.050T | ($0.750T) | ($1.013T) | ($0.635T) | ($0.516T) |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.156T) | $0.671T | $0.570T | $0.819T | $0.621T |
| FCF Margin %(computed) | -1.11% | 4.58% | 4.28% | 5.73% | 5.28% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · JPY · T
深入了解Mitsui & Co., Ltd.
关于Mitsui & Co., Ltd.（MITSF）现金流量表
Mitsui & Co., Ltd. 2026财年经营活动现金流$958.91B，自由现金流($156.47B)（FCF利润率-1.11%），资本支出($1115.38B)。
常见问题
MITSF · 4 问Mitsui & Co., Ltd. 2026财年自由现金流($156.47B)，同比down123.3%。
MITSF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10